Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-06

Clinical Trial Update: Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

View source ↗

Summary

Astellas is conducting a Japan post-marketing surveillance study to assess the safety and effectiveness of peficitinib in patients with rheumatoid arthritis, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • peficitinib (peficitinib)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Rheumatoid Arthritis (RA) | Status: RECRUITING